Respiratory syncytial virus (RSV) is associated with an increased risk of cardiovascular (CV) events, particularly among individuals with pre-existing CV disease. A bivalent RSV prefusion F protein-based (RSVpreF) vaccine demonstrated effectiveness against RSV-related hospitalization outcomes in the first season...
M. Pareek, M. Lassen, M. Yafasov et al.· European Heart Journal· 0 citations
Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an increased risk of heart failure, particularly heart failure with preserved ejection fraction (HFpEF). The prevalence of HFpEF and related patient-reported functional limitations in MASLD patients with preserved left ventricular...
M. Ramadan, F. S. Davidovski, C. Espersen et al.· European Heart Journal· 0 citations
The clinical relevance of left atrial (LA) dysfunction in acute heart failure (AHF) is unclear. Whether LA strain reflects disease mechanisms and predicts adverse outcomes in this heterogeneous population remains insufficiently investigated.
The aim was to examine the relationships between LA reservoir str...
M. Pedersen, F. Davidovski, C. Espersen et al.· European Heart Journal· 0 citations
Metabolic dysfunction associated steatotic liver disease (MASLD) is closely linked with cardiometabolic risk, but how cardiometabolic burden translates into early cardiac dysfunction in MASLD remains incompletely characterized. We evaluated whether higher cardiovascular-kidney-metabolic (CKM) syndrome stage was a...
A. Stanchev, F. D. Davidovski, C. E. Caroline Espersen et al.· European Heart Journal· 0 citations
AIM
This trial investigated whether colchicine, an anti-inflammatory treatment, affects cardiovascular structure and function, assessed by arterial stiffness, blood pressure and biochemistry, compared with placebo.
METHODS
COHERENT was a randomized, double-blind, placebo-controlled trial of the effects of colchicine...
A. Langhoff, N. Johansen, K. Bartholdy et al.· European Journal of Preventi...· 0 citations
BACKGROUND
Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...
M. Lassen, S. Christensen, M. Yafasov et al.· NEJM Evidence· 1 citation
BACKGROUND
Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty...
C. Espersen, N. Johansen, D. Modin et al.· The Lancet Healthy Longevity· 0 citations
Abstract Introduction Sex differences in chronic heart failure are well established, but corresponding differences in acute heart failure (AHF), particularly in multimodal imaging findings and short-term recovery, remain incompletely characterized. Methods In this prospective observational study, 567 adults hospitalize...
A. Khoraizat, F. Davidovski, C. Espersen et al.· ESC Heart Failure· 0 citations
Acute heart failure (AHF) is a major global health challenge, yet the relationship between New York Heart Association (NYHA) classification and objective markers such as echocardiography, lung ultrasound (LUS), and biomarkers remains unclear.
A. Al-Rubai, F. Davidovski, C. Espersen et al.· Echocardiography· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
